SlideShare a Scribd company logo
1 of 43
INCOMPATIBILITIES IN PRESCRIPTION
Definition of Incompatibility:
Incompatibility occurs as a result of
mixing of two or more “Antagonistic Substances” & an undesirable
product is formed which may affect the safety, efficacy & appearance
of the pharmaceutical preparation.
Types of Incompatibility:
Physicochemical Incompatibility
A) Physical incompatibility
B) Chemical incompatibility
Therapeutic incompatibility
Physicochemical Incompatibilty
If mixing two or more drugs or a drug &
excipients, by particular method, results in a
physicochemical change in the properties of drug
or dosage form, or production of a new chemical
substance having different pharmacological
action, it is called as physicochemical
incompatibility.
If incompatibility is prevented by addition,
substitution or elimination of one or more
ingredient is called as adjusted incompatibility.
General Methods used to remove
incompatibilities.
1.Modify the order of mixing
2.Dispense with labels like Shake well before use
3.Recommend storage condition.
4.Add physical stabilizer. (Suspending or
emulsifying agent)
5.Add chemical stabilizer. (Antioxidant/Buffer)
6.Add preservative.
7.Select soluble , compatible or stable form of
dosage form.
A] PHYSICAL INCOMPATIBILITY
 When two or more than two substances combined together a
physical change takes place & unacceptable product is formed.
Physical changes involves such as Immiscibility, Insolubility,
Precipitation formation or liquefaction of solid materials.
 The physical incompatibilities may be corrected by using any one or
more of the following methods:
i) Change the order of mixing of ingredients of the prescription.
ii) Emulsification
iii) Addition of suspending agent
iv) Change in the form of ingredients
v) By addition, substitution or omission of therapeutically inactive
sub.to help in compounding of the prescription.
Example of Physical Incompatibility & Their Methods
of Correction:
1.Immiscibility: Oils & Water are immiscible with each other.
They can be made miscible with water by emulsification.
Example:
Rx
Castor oil 15ml
water upto 60ml
Make an emulsion.
To overcome this incompatibility an emulsifying agent is used to
make a good emulsion.
2. Insolubility:
It means the inability of material to dissolve in a particular solvent
system.
The liquid preparations containing Indiffusible solids such as chalk,
aromatic chalk powder, acetyl salicylic acid, phenacetin, zinc oxide &
calamine etc.
 Suspending agent
- Increase the thickness of the preparation.
-Uniform distribution of the insoluble substances which
facilitating uniform measurement of each dose.
E.g Acacia,Tragacanth,SLS,etc
Example:
Rx
Phenacetin 3g
Caffeine 1g
Orange syrup 12ml
Water upto 90ml
Make a mixture.
In this prescription phenacetin is an indiffusible sub.
Compound powder of tragacanth or mucilage of tragacanth is used as
a suspending agent to make a stable suspension.
3. Settling Suspending agent
The drug in mixtures containing insoluble
solids(Suspension), during storage settles at the bottom.
Insoluble solids are of two types.
Diffusible Solids – Kaolin & light magnesium
carbonate remains evenly distributed.
Indiffusible solids – Chalk , Calamine --- Has to
increase viscosity of vehicles by adding
suspending agent like gum tragacanth.
4. Poor Wettability Levigating agent
Some drugs are poorly wetted with given
vehicle hence these may float or sink at
the bottom of vehicle. Hence levigation of
these solids with wetting agent such as
glycerine, propylene glycol, or hydrophilic
surfactant helps in the uniform
distribution of hydrophobic drug in water.
Eg. Sulphur lotion.
5. Precipitation:
A drug in solution may be precipitated , if the solvent in
which it is insoluble is added to the solution e.g. resins are
insoluble in water.
Volatile oils are soluble in alcohol. When water is added
into the alcoholic solution of volatile oil, the non aromatic
portion of the oil get precipitated & turbidity appears.
 Cap – locking  Co-solvents
Liquid preparations especially those containing syrups may
show crystallization of sugar in the closure , resulting in cap
locking. It can be minimized by adding co-solvents like
glycerine, propylene glycol or sorbitol
6. Grainy Semisolids  Non uniform cooling
Partial solidification of higher melting point
waxes may occur when cool spatula is used
for mixing or when a hot product is poured
in a cool container.
Grains are also developed during preparation
of creams, if the aqueous phase & oil phase
do not have same temperatures at the time
of mixing. This can be prevented by avoiding
localized cooling.
7. Liquefaction:
Eutectic mixture
 If low melting point solids are mixed together, a liquid or soft mass
known as ‘Eutectic mixture’ is produced.
This occurs due to the lowering of the melting point of mixture to
below the room temp. & liberation of water of hydration.
 e.g camphor, menthol, thymol.
Liquefication can be corrected by
i) Dispensing individual ingredient separately
ii) Compounding powder using diluents such as
lactose, magnesium oxide or magnesium
hydroxide are separately mixed with eutectic
substances and such mixtures are mixed to
produce final product.
This prevents physical contact of liquifiable
substances.
iii) Allowing completion of liquefaction & absorbing
the liquid using adsorbent such as substances like
kaolin.
B] CHEMICAL INCOMPATIBILITY
DEFINITION:
It may be as a result of chemical interactions between the
ingredients of a prescription & a toxic or inactive product may be
formed.
 It is due to oxidation-reduction, acid base hydrolysis or combination
reactions.
These reactions may be noticed by effervescence, decomposition,
colour change .
Chemical incompatibilities
are of following types.
1. Precipitation:
• Precipitation of the drug takes place due to -
i. pH change
ii. A chemical reaction between drug-drug or
drug-additives.
• When the ppt product is therapeutically active it is
formulated as per the procedure used to prepare
mixtures containing diffusible & indiffusible solid.
• If the resultant ppt is inactive or toxic the formulation
should be rejected.
a)pH Change:
•) Most of the medicines are often salts of weak acids
& weak bases.
•) The unionized forms are insoluble in water &
ionisable salts are soluble in water.
•) A pH change, not only changes solubility, but it also
changes rate of degradation.
•) If the resultant precipitate has therapeutic value &
it is chemical stable, one can tolerate the
incompatility.
•) A suitable co-solvent can be used to increase
solubility, otherwise a suspension is formulated.
• Eg. Morphine hydrochloride above 2.5 %
concentration , is insoluble & results in the
formation of diffusible precipitate under
alkaline condition.
• The solubility of precipitated morphine in
alcohol is 1 in 100.
• Thus incompatibility can be treated either by –
i) Preparing suspension of diffusible precipitate
Ii) Using alcohol as co-solvent to prepare
solution.
Eg. 2 )
Caffeine citrate above 2.2 %
concentration, under alkaline
condition produces indiffusible
precipitate but
when alcohol is used, it tolerates a
higher concentration of caffeine citrate
without precipitation.
b) Precipitation by chemical reaction:
i) Drug-drug interactions:
Eg. Caffeine Citrate
•) Active ingredients react with other drugs or additives yielding
diffusible or indiffusible precipitate.
•) Caffeine citrate is a mixture of equal weight of caffeine & citric
acid.
•) The citric acid reacts with sodium salicylate to liberate
salicylic acid in the form of precipitate.
•) It causes gastric irritation.
•) Hence only caffeine is used, it forms a soluble complexes with
sodium salicylate.
•) Therefore, caffeine citrate should be replaced with half the
amount of caffeine to get clear solution.
Flavour-
• Liquorice looses its flavour due to
precipitation in presence of acid.
• Acid reacts with glycyrrhizin, a
flavouring constituent of liquorice
forming glycyrrhizic acid precipitate.
2.Redox reaction:
Some drugs or their dosage forms undergo
oxidation when exposed to air, excessive
temperature & due to over dilution of liquids,
incorrect pH or presence of catalyst.
The common catalyst includes metal ions,
enzymes & bacteria.
The drug in the liquid state is more sensitive to
oxidation than insoluble state .
a) Auto oxidation of oils, fats,
phenolic substances, aldehydes &
vitamins.
•This can be prevented by addition
of primary antioxidants such as
alpha tocopherol, or BHT.
b) Paraaldehyde, tannins, epinephrine,
sulphacetamide & related compounds
undergo oxidation activated by heat.
• Hence for such drugs requires against trace metal
ions.
• This can be achieved by adding antioxidants such as
ascorbic acid, sodium metabisulfite or complexing
agents like EDTA are used to control oxidation.
c) Preparations containing riboflavin, folic acid &
ascorbic acid show incompatibility. Riboflavin is light
sensitive, and easily degraded by heat and light. Hence
should be stored at its stable pH 6 to 6.5.
D) When dry powders contains both
oxidising & reducing agents, the mixture
may explode.
•The inter-particulate friction developed
during mixing increases chances of redox
reaction.
•Therefore such reacting substances should
be dispensed separately or powders should
be mixed lightly by spatulation method.
3. Hydrolysis
• Hydrolysis can be controlled by avoiding moisture contact or by
changing pH.
• Aspirin is more sensitive to water & gets converted to more
irritant acetyl salicylic acid. Hence it is granulared without use of
water.
• Paracetamol is stable between ph 5 & 7 .
• While ibuprofen shows more solubility above pH 6.
Therefore compound suspension of these two drugs in
combination pH of solution is 5-6.
4. Racemisation
The conversion of an optically active
form to an optically inactive form
without changing chemical constitution
usually results in reduced therapeutic
activity.
5. Effervescence :
Two or more ingredients of formulation reacts to generate
CO2,
To overcome such reactions either -
a) Mix the reacting ingredients in open container & allow
to complete reaction before
filling in to container. The rate of reaction can be
increased by using hot water.
b) Change the one or more reacting ingredients.
c) Dispense reacting substances seperately
6. Colour change
The colour change is visible
incompatibility. When the colour reaction
is rapid it is allowed to complete before
dispensing.
The delayed color change in formulation
creates confusion in the mind of patient.
Eg.
Sodium Salicylate mixture BPC
During storage the alkaline solution
undergoes oxidation by atmospheric oxygen
& becomes brownish black.
The coloured product is safe and has
therapeutic value but it may create
confusion in the mind of patient
Hence anti-oxidant like sodium
metabisulphite is added as antioxidant to
control oxidation.
7. Incompatibilty with containers:
The product filled in a container may react
chemically with the container or get absorbed
by the container or the closure.
i) Glass containers alkali leaching.
ii) Rubber closures may adsorb preservatives.
iii) Metal containers catalyse rate of chemical
reaction.
THERAPEUTIC INCOMPATIBILITY
It is result of prescribing certain
drugs to a patient with the intention
to produce a specific degree of
p’cological action, but nature or
intensity of the action produced is
different from that intended by the
prescriber.
Therapeutic incompatibility is due to :
A) Medication errors
B) Drug interactions
A) Medication Errors:
Medication errors done by doctors, pharmacists, nurses & patients.
Medication errors can be categorized as –
1. Prescription errors
2. Dispensing errors
3. Selection errors
4. Bagging errors
5. Administration errors
1. Errors in prescription writing
The prescription should be neatly & correctly written
by the medical practitioner, otherwise it is major
hassle for the pharmacists.
- Spelling mistakes.
- Illegible handwriting.
a) SALA Medicines(Sound Alike Look Alike):
Tab. Dulcolax a laxative tablet & Tab . Duoclox an antibacterial tablet.
b) Type of dosage form:
Same drug can be available in tablet, capsule or liquid oral
dosage forms for adults, drops for pediatric patients.
Selection of dosage form is based on ability of patients to
take that medicines.
C) Strength of Medicines :
Some medicines, especially those whose
dosing is critical , are available in different
strengths. Eg. Haloperidol , antipsychotic
drug available in the form of tablets of
various strength viz. 0.25, 2mg, 5mg,10mg,
20 mg.
d) Quantity to be dispensed:
Pharmacists should check the dose & see
that the quantity of medicine is sufficient
to complete a course.
e) Dose & Direction:
Pharmacists should check the
dose, dosage regimen & direction
to use.
2. Dispensing Errors:
a)Poor handwriting
b)Long prescription
c)Incomplete patient information
d)Deviation in attention of pharmacist
e)Misunderstanding of verbal orders.
3. Selection of medicine
•While removing medicines
from shelves pharmacist
should be alert.
•He should remove the correct
medicine.
•SALA medicines should not be
kept adjacent to one another.
4. Bagging Errors:
After billing, dosage forms should
be packed in appropriate bags or
covers & handed over to the right
person.
5. Errors in administration
i) Breaking the coated or sustained
release tablets.
ii)Suspension administration without
shaking.
iii)Taking medicament at wrong time
before or after meal.
B) Drug interactions
1. Contra – indicated drugs:
There are certain drugs which may be contraindicated in a
particular disease or a particular patient who is allergic to
it.
Example: the penicillin & sulpha drugs are contraindicated
to the patients who are allergic to it.
2.Synergistic & antagonistic drugs:
Many drugs exhibit Synergism & Antagonism when
administered in combination.
When the two drugs are prescribed together, they tend
to increase the activity of each other, called as synergism.
Example: A combination of aspirin & paracetamol
increase the analgesic activity.
When two drugs having the opposing p’cological effects
are called antagonism.
Example: Acetyl salicylic acid and probenecid
c)Unintentional drug interaction
The effect of one drug is altered by the prior or
simultaneous administration of another drug.
Tetracycline hydrochloride 250mg
Direction –take one capsule with milk
Tetracycline inactive by calcium which is present
in milk.
d) Intentional drug interaction
Rx
Acetophenetidin 150mg
Acetyl salicylic acid 200mg
Caffeine 30mg
Send 10 capsules.
Acetophenetidin & acetyl salicylic acid are analgesic.
Acetophenetidin depresses the CNS & this effect is
undesirable.
Caffeine is CNS stimulant to neutralise the side effect of
acetophenetidin.

More Related Content

What's hot

Pharmaceutical Emulsion
Pharmaceutical EmulsionPharmaceutical Emulsion
Pharmaceutical EmulsionMirza Salman Baig
 
SOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTIONSOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTIONNithya Murugan
 
Impurities and their limit test
Impurities and their limit testImpurities and their limit test
Impurities and their limit testESHA SHAH
 
Pharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and EmulsionsPharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and EmulsionsPallavi Kurra
 
Liquid Dosage Form
Liquid Dosage FormLiquid Dosage Form
Liquid Dosage Formphmosarrof
 
Pharmaceutical excipients
Pharmaceutical excipientsPharmaceutical excipients
Pharmaceutical excipientssaimsoleja
 
Semisolid dosage forms ppt
Semisolid dosage forms pptSemisolid dosage forms ppt
Semisolid dosage forms pptPranatiChavan
 
Pharmaceutical additives for liquid dosage form
Pharmaceutical additives for liquid dosage formPharmaceutical additives for liquid dosage form
Pharmaceutical additives for liquid dosage formchetan jain
 
PARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTION
PARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTIONPARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTION
PARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTIONVenkat Kcl
 
B.pharm- semisolid dosage form
B.pharm- semisolid dosage formB.pharm- semisolid dosage form
B.pharm- semisolid dosage formArshad Khan
 
Chemical incompatibility
Chemical incompatibilityChemical incompatibility
Chemical incompatibilitySaif Khan
 
Liquid dosage form
Liquid dosage form Liquid dosage form
Liquid dosage form ROHIT YADAV
 
BIPHASIC LIQUID DOSAGE FORMS priyanka kandhare
BIPHASIC LIQUID DOSAGE FORMS priyanka kandhareBIPHASIC LIQUID DOSAGE FORMS priyanka kandhare
BIPHASIC LIQUID DOSAGE FORMS priyanka kandharePriyanka Kandhare
 
Semisolid dosage form..
Semisolid dosage form..Semisolid dosage form..
Semisolid dosage form..Rabab Ambreen
 
Test for identification of type of emulsion
Test for identification of type of emulsionTest for identification of type of emulsion
Test for identification of type of emulsionSantuMistree4
 

What's hot (20)

Pharmaceutical Emulsion
Pharmaceutical EmulsionPharmaceutical Emulsion
Pharmaceutical Emulsion
 
SOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTIONSOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTION
 
Impurities and their limit test
Impurities and their limit testImpurities and their limit test
Impurities and their limit test
 
Pharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and EmulsionsPharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and Emulsions
 
Liquid Dosage Form
Liquid Dosage FormLiquid Dosage Form
Liquid Dosage Form
 
Pharmaceutical Suspension
Pharmaceutical SuspensionPharmaceutical Suspension
Pharmaceutical Suspension
 
Sources of impurities
Sources of impuritiesSources of impurities
Sources of impurities
 
Pharmaceutical excipients
Pharmaceutical excipientsPharmaceutical excipients
Pharmaceutical excipients
 
Semisolid dosage forms ppt
Semisolid dosage forms pptSemisolid dosage forms ppt
Semisolid dosage forms ppt
 
Pharmaceutical additives for liquid dosage form
Pharmaceutical additives for liquid dosage formPharmaceutical additives for liquid dosage form
Pharmaceutical additives for liquid dosage form
 
Pharmacopoeia
PharmacopoeiaPharmacopoeia
Pharmacopoeia
 
PARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTION
PARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTIONPARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTION
PARTS OF PRESCRIPTION AND HANDLING OF PRESCRIPTION
 
B.pharm- semisolid dosage form
B.pharm- semisolid dosage formB.pharm- semisolid dosage form
B.pharm- semisolid dosage form
 
Chemical incompatibility
Chemical incompatibilityChemical incompatibility
Chemical incompatibility
 
Liquid dosage form
Liquid dosage form Liquid dosage form
Liquid dosage form
 
BIPHASIC LIQUID DOSAGE FORMS priyanka kandhare
BIPHASIC LIQUID DOSAGE FORMS priyanka kandhareBIPHASIC LIQUID DOSAGE FORMS priyanka kandhare
BIPHASIC LIQUID DOSAGE FORMS priyanka kandhare
 
Posology
PosologyPosology
Posology
 
The prescription
The prescriptionThe prescription
The prescription
 
Semisolid dosage form..
Semisolid dosage form..Semisolid dosage form..
Semisolid dosage form..
 
Test for identification of type of emulsion
Test for identification of type of emulsionTest for identification of type of emulsion
Test for identification of type of emulsion
 

Similar to Incompatibility in Prescription

Incompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptxIncompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptxAditya Sharma
 
Incompatibility l1
Incompatibility l1Incompatibility l1
Incompatibility l1Ahmad Ali
 
effect of various environment and processing on stability of formulations
effect of various environment and processing on stability of formulationseffect of various environment and processing on stability of formulations
effect of various environment and processing on stability of formulationsManoj Kumar Tekuri
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescriptionNisha Mhaske
 
pharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_nareshpharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_nareshNaresh Gorantla
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescriptionSantuMistree4
 
suspension.ppt
suspension.pptsuspension.ppt
suspension.pptavya8
 
suspension of medicated syrups for industry ppt
suspension of medicated syrups for industry pptsuspension of medicated syrups for industry ppt
suspension of medicated syrups for industry pptstiflexpharmaceutica
 
Drug stability consideration and degradation
Drug stability consideration and degradationDrug stability consideration and degradation
Drug stability consideration and degradationJalal Uddin
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxSUJITHA MARY
 
Accelerated Stability Testing.
Accelerated Stability Testing. Accelerated Stability Testing.
Accelerated Stability Testing. Maha Alkhalifah
 
Pharmaceutical incompatibilities
Pharmaceutical incompatibilitiesPharmaceutical incompatibilities
Pharmaceutical incompatibilitiesZainab&Sons
 
Physical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilitiesPhysical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilitiesshital trivedi
 
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxEXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxDhruv Bhavsar
 
Incompatibilities in prescriptions
Incompatibilities in prescriptionsIncompatibilities in prescriptions
Incompatibilities in prescriptionsPRAVEEN KUMAR CHEMBETI
 
Analysis of excipients of interest
Analysis of excipients of interestAnalysis of excipients of interest
Analysis of excipients of interestPHARMA WORLD
 

Similar to Incompatibility in Prescription (20)

Incompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptxIncompatibilities in Prescription.pptx
Incompatibilities in Prescription.pptx
 
Incompatibility l1
Incompatibility l1Incompatibility l1
Incompatibility l1
 
effect of various environment and processing on stability of formulations
effect of various environment and processing on stability of formulationseffect of various environment and processing on stability of formulations
effect of various environment and processing on stability of formulations
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescription
 
pharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_nareshpharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_naresh
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescription
 
suspension.ppt
suspension.pptsuspension.ppt
suspension.ppt
 
suspension of medicated syrups for industry ppt
suspension of medicated syrups for industry pptsuspension of medicated syrups for industry ppt
suspension of medicated syrups for industry ppt
 
Suspension.pptx
Suspension.pptxSuspension.pptx
Suspension.pptx
 
Drug stability consideration and degradation
Drug stability consideration and degradationDrug stability consideration and degradation
Drug stability consideration and degradation
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptx
 
Accelerated Stability Testing.
Accelerated Stability Testing. Accelerated Stability Testing.
Accelerated Stability Testing.
 
Drug stability
Drug stabilityDrug stability
Drug stability
 
Pharmaceutical incompatibilities
Pharmaceutical incompatibilitiesPharmaceutical incompatibilities
Pharmaceutical incompatibilities
 
SUSPENSION.ppt
SUSPENSION.pptSUSPENSION.ppt
SUSPENSION.ppt
 
Physical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilitiesPhysical incompatibilities and chemical incompatibilities
Physical incompatibilities and chemical incompatibilities
 
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxEXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
 
emulsion
emulsionemulsion
emulsion
 
Incompatibilities in prescriptions
Incompatibilities in prescriptionsIncompatibilities in prescriptions
Incompatibilities in prescriptions
 
Analysis of excipients of interest
Analysis of excipients of interestAnalysis of excipients of interest
Analysis of excipients of interest
 

More from bvocmithilesh

Med chem unit2
Med chem unit2Med chem unit2
Med chem unit2bvocmithilesh
 
Medicinal chemistry unit1&3
Medicinal chemistry unit1&3Medicinal chemistry unit1&3
Medicinal chemistry unit1&3bvocmithilesh
 
Incompatibilities.ppt
Incompatibilities.pptIncompatibilities.ppt
Incompatibilities.pptbvocmithilesh
 
Size saperation introduction
Size saperation introductionSize saperation introduction
Size saperation introductionbvocmithilesh
 
Pharmaceutical labelling
Pharmaceutical labellingPharmaceutical labelling
Pharmaceutical labellingbvocmithilesh
 
Pharmaceutical packaging
Pharmaceutical packagingPharmaceutical packaging
Pharmaceutical packagingbvocmithilesh
 
High performance liquid chromatography as introduction
High performance liquid chromatography as introductionHigh performance liquid chromatography as introduction
High performance liquid chromatography as introductionbvocmithilesh
 
Paper & TLC Chromatography
Paper & TLC ChromatographyPaper & TLC Chromatography
Paper & TLC Chromatographybvocmithilesh
 

More from bvocmithilesh (11)

Med chem unit2
Med chem unit2Med chem unit2
Med chem unit2
 
Medicinal chemistry unit1&3
Medicinal chemistry unit1&3Medicinal chemistry unit1&3
Medicinal chemistry unit1&3
 
Incompatibilities.ppt
Incompatibilities.pptIncompatibilities.ppt
Incompatibilities.ppt
 
Size saperation introduction
Size saperation introductionSize saperation introduction
Size saperation introduction
 
Pharmaceutical labelling
Pharmaceutical labellingPharmaceutical labelling
Pharmaceutical labelling
 
Pharmaceutical packaging
Pharmaceutical packagingPharmaceutical packaging
Pharmaceutical packaging
 
Dosage forms
Dosage formsDosage forms
Dosage forms
 
Prescription
PrescriptionPrescription
Prescription
 
Gmp glp
Gmp glpGmp glp
Gmp glp
 
High performance liquid chromatography as introduction
High performance liquid chromatography as introductionHigh performance liquid chromatography as introduction
High performance liquid chromatography as introduction
 
Paper & TLC Chromatography
Paper & TLC ChromatographyPaper & TLC Chromatography
Paper & TLC Chromatography
 

Recently uploaded

GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptMAESTRELLAMesa2
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfWadeK3
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...SĂŠrgio Sacani
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzohaibmir069
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSĂŠrgio Sacani
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSĂŠrgio Sacani
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfSwapnil Therkar
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSĂŠrgio Sacani
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 

Recently uploaded (20)

GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.ppt
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistan
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 

Incompatibility in Prescription

  • 1. INCOMPATIBILITIES IN PRESCRIPTION Definition of Incompatibility: Incompatibility occurs as a result of mixing of two or more “Antagonistic Substances” & an undesirable product is formed which may affect the safety, efficacy & appearance of the pharmaceutical preparation. Types of Incompatibility: Physicochemical Incompatibility A) Physical incompatibility B) Chemical incompatibility Therapeutic incompatibility
  • 2. Physicochemical Incompatibilty If mixing two or more drugs or a drug & excipients, by particular method, results in a physicochemical change in the properties of drug or dosage form, or production of a new chemical substance having different pharmacological action, it is called as physicochemical incompatibility. If incompatibility is prevented by addition, substitution or elimination of one or more ingredient is called as adjusted incompatibility.
  • 3. General Methods used to remove incompatibilities. 1.Modify the order of mixing 2.Dispense with labels like Shake well before use 3.Recommend storage condition. 4.Add physical stabilizer. (Suspending or emulsifying agent) 5.Add chemical stabilizer. (Antioxidant/Buffer) 6.Add preservative. 7.Select soluble , compatible or stable form of dosage form.
  • 4. A] PHYSICAL INCOMPATIBILITY  When two or more than two substances combined together a physical change takes place & unacceptable product is formed. Physical changes involves such as Immiscibility, Insolubility, Precipitation formation or liquefaction of solid materials.  The physical incompatibilities may be corrected by using any one or more of the following methods: i) Change the order of mixing of ingredients of the prescription. ii) Emulsification iii) Addition of suspending agent iv) Change in the form of ingredients v) By addition, substitution or omission of therapeutically inactive sub.to help in compounding of the prescription.
  • 5. Example of Physical Incompatibility & Their Methods of Correction: 1.Immiscibility: Oils & Water are immiscible with each other. They can be made miscible with water by emulsification. Example: Rx Castor oil 15ml water upto 60ml Make an emulsion. To overcome this incompatibility an emulsifying agent is used to make a good emulsion.
  • 6. 2. Insolubility: It means the inability of material to dissolve in a particular solvent system. The liquid preparations containing Indiffusible solids such as chalk, aromatic chalk powder, acetyl salicylic acid, phenacetin, zinc oxide & calamine etc.  Suspending agent - Increase the thickness of the preparation. -Uniform distribution of the insoluble substances which facilitating uniform measurement of each dose. E.g Acacia,Tragacanth,SLS,etc
  • 7. Example: Rx Phenacetin 3g Caffeine 1g Orange syrup 12ml Water upto 90ml Make a mixture. In this prescription phenacetin is an indiffusible sub. Compound powder of tragacanth or mucilage of tragacanth is used as a suspending agent to make a stable suspension.
  • 8. 3. Settling Suspending agent The drug in mixtures containing insoluble solids(Suspension), during storage settles at the bottom. Insoluble solids are of two types. Diffusible Solids – Kaolin & light magnesium carbonate remains evenly distributed. Indiffusible solids – Chalk , Calamine --- Has to increase viscosity of vehicles by adding suspending agent like gum tragacanth.
  • 9. 4. Poor Wettability Levigating agent Some drugs are poorly wetted with given vehicle hence these may float or sink at the bottom of vehicle. Hence levigation of these solids with wetting agent such as glycerine, propylene glycol, or hydrophilic surfactant helps in the uniform distribution of hydrophobic drug in water. Eg. Sulphur lotion.
  • 10. 5. Precipitation: A drug in solution may be precipitated , if the solvent in which it is insoluble is added to the solution e.g. resins are insoluble in water. Volatile oils are soluble in alcohol. When water is added into the alcoholic solution of volatile oil, the non aromatic portion of the oil get precipitated & turbidity appears.  Cap – locking  Co-solvents Liquid preparations especially those containing syrups may show crystallization of sugar in the closure , resulting in cap locking. It can be minimized by adding co-solvents like glycerine, propylene glycol or sorbitol
  • 11. 6. Grainy Semisolids  Non uniform cooling Partial solidification of higher melting point waxes may occur when cool spatula is used for mixing or when a hot product is poured in a cool container. Grains are also developed during preparation of creams, if the aqueous phase & oil phase do not have same temperatures at the time of mixing. This can be prevented by avoiding localized cooling.
  • 12. 7. Liquefaction: Eutectic mixture  If low melting point solids are mixed together, a liquid or soft mass known as ‘Eutectic mixture’ is produced. This occurs due to the lowering of the melting point of mixture to below the room temp. & liberation of water of hydration.  e.g camphor, menthol, thymol.
  • 13. Liquefication can be corrected by i) Dispensing individual ingredient separately ii) Compounding powder using diluents such as lactose, magnesium oxide or magnesium hydroxide are separately mixed with eutectic substances and such mixtures are mixed to produce final product. This prevents physical contact of liquifiable substances. iii) Allowing completion of liquefaction & absorbing the liquid using adsorbent such as substances like kaolin.
  • 14. B] CHEMICAL INCOMPATIBILITY DEFINITION: It may be as a result of chemical interactions between the ingredients of a prescription & a toxic or inactive product may be formed.  It is due to oxidation-reduction, acid base hydrolysis or combination reactions. These reactions may be noticed by effervescence, decomposition, colour change .
  • 15. Chemical incompatibilities are of following types. 1. Precipitation: • Precipitation of the drug takes place due to - i. pH change ii. A chemical reaction between drug-drug or drug-additives. • When the ppt product is therapeutically active it is formulated as per the procedure used to prepare mixtures containing diffusible & indiffusible solid. • If the resultant ppt is inactive or toxic the formulation should be rejected.
  • 16. a)pH Change: •) Most of the medicines are often salts of weak acids & weak bases. •) The unionized forms are insoluble in water & ionisable salts are soluble in water. •) A pH change, not only changes solubility, but it also changes rate of degradation. •) If the resultant precipitate has therapeutic value & it is chemical stable, one can tolerate the incompatility. •) A suitable co-solvent can be used to increase solubility, otherwise a suspension is formulated.
  • 17. • Eg. Morphine hydrochloride above 2.5 % concentration , is insoluble & results in the formation of diffusible precipitate under alkaline condition. • The solubility of precipitated morphine in alcohol is 1 in 100. • Thus incompatibility can be treated either by – i) Preparing suspension of diffusible precipitate Ii) Using alcohol as co-solvent to prepare solution.
  • 18. Eg. 2 ) Caffeine citrate above 2.2 % concentration, under alkaline condition produces indiffusible precipitate but when alcohol is used, it tolerates a higher concentration of caffeine citrate without precipitation.
  • 19. b) Precipitation by chemical reaction: i) Drug-drug interactions: Eg. Caffeine Citrate •) Active ingredients react with other drugs or additives yielding diffusible or indiffusible precipitate. •) Caffeine citrate is a mixture of equal weight of caffeine & citric acid. •) The citric acid reacts with sodium salicylate to liberate salicylic acid in the form of precipitate. •) It causes gastric irritation. •) Hence only caffeine is used, it forms a soluble complexes with sodium salicylate. •) Therefore, caffeine citrate should be replaced with half the amount of caffeine to get clear solution.
  • 20. Flavour- • Liquorice looses its flavour due to precipitation in presence of acid. • Acid reacts with glycyrrhizin, a flavouring constituent of liquorice forming glycyrrhizic acid precipitate.
  • 21. 2.Redox reaction: Some drugs or their dosage forms undergo oxidation when exposed to air, excessive temperature & due to over dilution of liquids, incorrect pH or presence of catalyst. The common catalyst includes metal ions, enzymes & bacteria. The drug in the liquid state is more sensitive to oxidation than insoluble state .
  • 22. a) Auto oxidation of oils, fats, phenolic substances, aldehydes & vitamins. •This can be prevented by addition of primary antioxidants such as alpha tocopherol, or BHT. b) Paraaldehyde, tannins, epinephrine, sulphacetamide & related compounds undergo oxidation activated by heat.
  • 23. • Hence for such drugs requires against trace metal ions. • This can be achieved by adding antioxidants such as ascorbic acid, sodium metabisulfite or complexing agents like EDTA are used to control oxidation. c) Preparations containing riboflavin, folic acid & ascorbic acid show incompatibility. Riboflavin is light sensitive, and easily degraded by heat and light. Hence should be stored at its stable pH 6 to 6.5.
  • 24. D) When dry powders contains both oxidising & reducing agents, the mixture may explode. •The inter-particulate friction developed during mixing increases chances of redox reaction. •Therefore such reacting substances should be dispensed separately or powders should be mixed lightly by spatulation method.
  • 25. 3. Hydrolysis • Hydrolysis can be controlled by avoiding moisture contact or by changing pH. • Aspirin is more sensitive to water & gets converted to more irritant acetyl salicylic acid. Hence it is granulared without use of water. • Paracetamol is stable between ph 5 & 7 . • While ibuprofen shows more solubility above pH 6. Therefore compound suspension of these two drugs in combination pH of solution is 5-6.
  • 26. 4. Racemisation The conversion of an optically active form to an optically inactive form without changing chemical constitution usually results in reduced therapeutic activity.
  • 27. 5. Effervescence : Two or more ingredients of formulation reacts to generate CO2, To overcome such reactions either - a) Mix the reacting ingredients in open container & allow to complete reaction before filling in to container. The rate of reaction can be increased by using hot water. b) Change the one or more reacting ingredients. c) Dispense reacting substances seperately
  • 28. 6. Colour change The colour change is visible incompatibility. When the colour reaction is rapid it is allowed to complete before dispensing. The delayed color change in formulation creates confusion in the mind of patient.
  • 29. Eg. Sodium Salicylate mixture BPC During storage the alkaline solution undergoes oxidation by atmospheric oxygen & becomes brownish black. The coloured product is safe and has therapeutic value but it may create confusion in the mind of patient Hence anti-oxidant like sodium metabisulphite is added as antioxidant to control oxidation.
  • 30. 7. Incompatibilty with containers: The product filled in a container may react chemically with the container or get absorbed by the container or the closure. i) Glass containers alkali leaching. ii) Rubber closures may adsorb preservatives. iii) Metal containers catalyse rate of chemical reaction.
  • 31. THERAPEUTIC INCOMPATIBILITY It is result of prescribing certain drugs to a patient with the intention to produce a specific degree of p’cological action, but nature or intensity of the action produced is different from that intended by the prescriber.
  • 32. Therapeutic incompatibility is due to : A) Medication errors B) Drug interactions A) Medication Errors: Medication errors done by doctors, pharmacists, nurses & patients. Medication errors can be categorized as – 1. Prescription errors 2. Dispensing errors 3. Selection errors 4. Bagging errors 5. Administration errors
  • 33. 1. Errors in prescription writing The prescription should be neatly & correctly written by the medical practitioner, otherwise it is major hassle for the pharmacists. - Spelling mistakes. - Illegible handwriting. a) SALA Medicines(Sound Alike Look Alike): Tab. Dulcolax a laxative tablet & Tab . Duoclox an antibacterial tablet. b) Type of dosage form: Same drug can be available in tablet, capsule or liquid oral dosage forms for adults, drops for pediatric patients. Selection of dosage form is based on ability of patients to take that medicines.
  • 34. C) Strength of Medicines : Some medicines, especially those whose dosing is critical , are available in different strengths. Eg. Haloperidol , antipsychotic drug available in the form of tablets of various strength viz. 0.25, 2mg, 5mg,10mg, 20 mg. d) Quantity to be dispensed: Pharmacists should check the dose & see that the quantity of medicine is sufficient to complete a course.
  • 35. e) Dose & Direction: Pharmacists should check the dose, dosage regimen & direction to use.
  • 36. 2. Dispensing Errors: a)Poor handwriting b)Long prescription c)Incomplete patient information d)Deviation in attention of pharmacist e)Misunderstanding of verbal orders.
  • 37. 3. Selection of medicine •While removing medicines from shelves pharmacist should be alert. •He should remove the correct medicine. •SALA medicines should not be kept adjacent to one another.
  • 38. 4. Bagging Errors: After billing, dosage forms should be packed in appropriate bags or covers & handed over to the right person.
  • 39. 5. Errors in administration i) Breaking the coated or sustained release tablets. ii)Suspension administration without shaking. iii)Taking medicament at wrong time before or after meal.
  • 40. B) Drug interactions 1. Contra – indicated drugs: There are certain drugs which may be contraindicated in a particular disease or a particular patient who is allergic to it. Example: the penicillin & sulpha drugs are contraindicated to the patients who are allergic to it.
  • 41. 2.Synergistic & antagonistic drugs: Many drugs exhibit Synergism & Antagonism when administered in combination. When the two drugs are prescribed together, they tend to increase the activity of each other, called as synergism. Example: A combination of aspirin & paracetamol increase the analgesic activity. When two drugs having the opposing p’cological effects are called antagonism. Example: Acetyl salicylic acid and probenecid
  • 42. c)Unintentional drug interaction The effect of one drug is altered by the prior or simultaneous administration of another drug. Tetracycline hydrochloride 250mg Direction –take one capsule with milk Tetracycline inactive by calcium which is present in milk.
  • 43. d) Intentional drug interaction Rx Acetophenetidin 150mg Acetyl salicylic acid 200mg Caffeine 30mg Send 10 capsules. Acetophenetidin & acetyl salicylic acid are analgesic. Acetophenetidin depresses the CNS & this effect is undesirable. Caffeine is CNS stimulant to neutralise the side effect of acetophenetidin.